Moderna (MRNA)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-02-11 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Moderna, Inc. (MRNA) CIK: 0001682852 --- Reporting Owner --- Name: Mock James M CIK: 0001736359 Role: Officer (Chief Financial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-02-11 | Code: A (Grant or award) Shares: +2,630 | Price: $0.00 Shares Owned After: 46,502 | Ownership: D (Direct) Footnotes: [F1] The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on February 28, 2023 (the "2023 PSUs"). [Transaction #2] Security: Common Stock Date: 2026-02-11 | Code: F (Payment of exercise/tax) Shares: -1,278 | Price: $41.99 Total Value: $53,663.22 Shares Owned After: 45,224 | Ownership: D (Direct) Footnotes: [F2] Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2023 PSUs. --- Footnotes (Complete Index) --- F1: The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on February 28, 2023 (the "2023 PSUs"). F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2023 PSUs. --- Signature --- /s/ /s/ James Dillon, As Attorney-in-Fact (2026-02-13)